These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32911318)

  • 21. "We only trust each other": A qualitative study exploring the overdose risk environment among persons who inject drugs living with HIV in Nairobi, Kenya.
    Maurano M; Bukusi D; Masyuko S; Bosire R; Gitau E; Guthrie BL; Monroe-Wise A; Musyoki H; Owuor MA; Sambai B; Sinkele W; Kingston H; Farquhar C; Mbogo L; Ludwig-Barron NT
    PLOS Glob Public Health; 2024; 4(7):e0003435. PubMed ID: 38954694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescription opioid injection among young people who inject drugs in New York City: a mixed-methods description and associations with hepatitis C virus infection and overdose.
    Mateu-Gelabert P; Guarino H; Zibbell JE; Teubl J; Fong C; Goodbody E; Edlin B; Salvati C; Friedman SR
    Harm Reduct J; 2020 Mar; 17(1):22. PubMed ID: 32228700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug use practices among people who inject drugs in a context of drug market changes: Challenges for optimal coverage of harm reduction programs.
    Roy É; Arruda N; Leclerc P; Morissette C; Blanchette C; Blouin K; Alary M
    Int J Drug Policy; 2017 Jul; 45():18-24. PubMed ID: 28575681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of non-fatal overdose and polysubstance use in a longitudinal study with people who inject drugs in Tijuana, Mexico.
    Rivera Saldana CD; Abramovitz D; Meacham MC; Gonzalez-Zuniga P; Rafful C; Rangel G; Strathdee SA; Cepeda J
    Drug Alcohol Rev; 2021 Nov; 40(7):1340-1348. PubMed ID: 34042226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Motivations for crystal methamphetamine-opioid co-injection/co-use amongst community-recruited people who inject drugs: a qualitative study.
    Palmer A; Scott N; Dietze P; Higgs P
    Harm Reduct J; 2020 Feb; 17(1):14. PubMed ID: 32106854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with chronic pain and non-medical opioid use among people who inject drugs.
    Bicket MC; Park JN; Torrie A; Allen ST; Weir BW; Sherman SG
    Addict Behav; 2020 Mar; 102():106172. PubMed ID: 31704433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polysubstance use trends and variability among individuals with opioid use disorder in rural versus urban settings.
    Ellis MS; Kasper ZA; Cicero TJ
    Prev Med; 2021 Nov; 152(Pt 2):106729. PubMed ID: 34293380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugs.
    Hughto JMW; Tapper A; Rapisarda SS; Stopka TJ; Palacios WR; Case P; Silcox J; Moyo P; Green TC
    Subst Abuse Treat Prev Policy; 2023 May; 18(1):30. PubMed ID: 37217975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
    Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
    Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Injecting Alone is More Common among Men, Frequent Injectors and Polysubstance Users in a Sample of People Who Inject Drugs.
    Gjersing L; Helle MK
    Subst Use Misuse; 2021; 56(14):2214-2220. PubMed ID: 34565289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of substance use and mortality risk in a cohort of 'hard-to-reach' polysubstance users.
    Gjersing L; Bretteville-Jensen AL
    Addiction; 2018 Apr; 113(4):729-739. PubMed ID: 28987019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High enhancer, downer, withdrawal helper: Multifunctional nonmedical benzodiazepine use among young adult opioid users in New York City.
    Mateu-Gelabert P; Jessell L; Goodbody E; Kim D; Gile K; Teubl J; Syckes C; Ruggles K; Lazar J; Friedman S; Guarino H
    Int J Drug Policy; 2017 Aug; 46():17-27. PubMed ID: 28577506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities.
    Estadt AT; Miller WC; Kline D; Whitney BM; Young AM; Todd Korthuis P; Stopka TJ; Feinberg J; Zule WA; Pho MT; Friedmann PD; Westergaard RP; Eagen KV; Seaman A; Ma J; Go VF; Lancaster KE
    Int J Drug Policy; 2023 Oct; ():104222. PubMed ID: 37806839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polysubstance Use Patterns among Justice-Involved Individuals Who Use Opioids.
    Bunting AM; Oser C; Staton M; Knudsen H
    Subst Use Misuse; 2020; 55(13):2165-2174. PubMed ID: 32686551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prescription drug use and misuse in a cohort of people who inject drugs (PWID) in Baltimore.
    Anagnostopoulos A; Abraham AG; Genberg BL; Kirk GD; Mehta SH
    Addict Behav; 2018 Jun; 81():39-45. PubMed ID: 29425791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatal overdose prevention and experience with naloxone: A cross-sectional study from a community-based cohort of people who inject drugs in Baltimore, Maryland.
    Buresh M; Gicquelais RE; Astemborski J; Kirk GD; Mehta SH; Genberg BL
    PLoS One; 2020; 15(3):e0230127. PubMed ID: 32160244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rates of perfect self-reported adherence to direct-acting antiviral therapy and its correlates among people who inject drugs on medications for opioid use disorder: The PREVAIL study.
    Pericot-Valverde I; Rennert L; Heo M; Akiyama MJ; Norton BL; Agyemang L; Lumsden B; Litwin AH
    J Viral Hepat; 2021 Mar; 28(3):548-557. PubMed ID: 33249689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
    Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
    Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Purposeful Fentanyl Use and Associated Factors among Opioid-Dependent People Who Inject Drugs.
    Chandra DK; Altice FL; Copenhaver MM; Zhou X; Didomizio E; Shrestha R
    Subst Use Misuse; 2021; 56(7):979-987. PubMed ID: 33769199
    [No Abstract]   [Full Text] [Related]  

  • 40. Opioid withdrawal symptoms, frequency, and pain characteristics as correlates of health risk among people who inject drugs.
    Bluthenthal RN; Simpson K; Ceasar RC; Zhao J; Wenger L; Kral AH
    Drug Alcohol Depend; 2020 Jun; 211():107932. PubMed ID: 32199668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.